US Stock MarketDetailed Quotes

SAGE Sage Therapeutics

Watchlist

7.140
-0.040-0.56%

Close Feb 14 16:00 ET

7.160
+0.020+0.28%

Post 20:01 ET

438.97MMarket Cap-1.08P/E (TTM)

Sage Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Sage Therapeutics Q4 2024 Earnings Date

Currency：USDFeb 11, 2025

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	14.37M	12.82M	-1.55M
Miss Est.	-81.57%	-83.56%	-10.81%
EPS	-1.53	-1.56	-0.03
Miss Est.	-178.20%	-188.89%	-1.97%

Analyst Rating

Hold

Feb 17, 2025

Sage Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 14 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q2	-- / 16.661M	--
--	2025/Q1	-- / 14.205M	--
Feb 11, 2025	2024/Q4	12.815M / 14.369M	--
Oct 29, 2024	2024/Q3	11.871M / 10.854M	--
Jul 31, 2024	2024/Q2	8.654M / 8.867M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q2-- / 16.661M--

--2025/Q1-- / 14.205M--

Feb 11, 20252024/Q412.815M / 14.369M--

Oct 29, 20242024/Q311.871M / 10.854M--

Jul 31, 20242024/Q28.654M / 8.867M--

Unlock Free Earnings Estimates

Open Account

Sage Therapeutics Earnings Reports

Sage Therapeutics | 8-K: Sage Therapeutics Announces Fourth Quarter and Full Year 2024 Financial Results and Highlights Pipeline and Business Updates

Feb 11 16:18 ET

Sage Therapeutics | 10-K: FY2024 Annual Report

Feb 11 16:16 ET

Sage Therapeutics | 10-Q: Q3 2024 Earnings Report

Oct 29, 2024 16:24 ET

Sage Therapeutics | 8-K: Sage Therapeutics Announces Third Quarter 2024 Financial Results and Highlights Pipeline and Business Updates

Oct 29, 2024 16:14 ET